A

Amneal Intermediate Inc
NASDAQ:AMRX

Watchlist Manager
Amneal Intermediate Inc
NASDAQ:AMRX
Watchlist
Price: 8.46 USD -2.76% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Amneal Intermediate Inc?
Write Note

Amneal Intermediate Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amneal Intermediate Inc
Other Liabilities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
A
Amneal Intermediate Inc
NASDAQ:AMRX
Other Liabilities
$78.7m
CAGR 3-Years
-17%
CAGR 5-Years
-19%
CAGR 10-Years
9%
Johnson & Johnson
NYSE:JNJ
Other Liabilities
$21.3B
CAGR 3-Years
-8%
CAGR 5-Years
-6%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Other Liabilities
$5B
CAGR 3-Years
-13%
CAGR 5-Years
1%
CAGR 10-Years
6%
Pfizer Inc
NYSE:PFE
Other Liabilities
$24.7B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
5%
Merck & Co Inc
NYSE:MRK
Other Liabilities
$7.3B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-1%
Eli Lilly and Co
NYSE:LLY
Other Liabilities
$7.4B
CAGR 3-Years
-8%
CAGR 5-Years
-1%
CAGR 10-Years
6%

See Also

What is Amneal Intermediate Inc's Other Liabilities?
Other Liabilities
78.7m USD

Based on the financial report for Dec 31, 2023, Amneal Intermediate Inc's Other Liabilities amounts to 78.7m USD.

What is Amneal Intermediate Inc's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
9%

Over the last year, the Other Liabilities growth was -46%. The average annual Other Liabilities growth rates for Amneal Intermediate Inc have been -17% over the past three years , -19% over the past five years , and 9% over the past ten years .

Back to Top